SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001764013-21-000065
Filing Date
2021-08-02
Accepted
2021-08-02 16:31:58
Documents
3
Period of Report
2021-08-02

Document Format Files

Seq Description Document Type Size
1 PRE 14A imvt-20210331prelimproxy.htm PRE 14A 603730
2 GRAPHIC immunovantinc_proxycard8-2b.jpg GRAPHIC 270002
3 GRAPHIC immunovantinc_proxycard8-2c.jpg GRAPHIC 182985
  Complete submission text file 0001764013-21-000065.txt   1228980
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: PRE 14A | Act: 34 | File No.: 001-38906 | Film No.: 211136449
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences